I think the only reason the price fell so much was due to the overtones of Pan Pharm. Its clear in this case the % drop is absolutely rubbish. The co. is still profitable and merely missed a forcast. If anyone out there has worked for large organisations forecasts are merely a guess at the best of times.
The stock has no issues with being a going concern so where is the justification in the drop??
- Forums
- ASX - By Stock
- LIP
- opportunity
LIP
lipa pharmaceuticals limited
opportunity
Featured News
Add LIP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online